Published in Equine Vet J on March 01, 1994
Proteolysis and antiproteolysis--a delicate balance. Equine Vet J (1994) 0.75
Computer-assisted follow-up register for the north-east of Scotland. Br Med J (1970) 3.92
Actin-like filaments in the cleavage furrow of newt egg. Exp Cell Res (1971) 3.53
RNA-DNA hybrids at the cytological level. Nature (1969) 2.81
Use of metronidazole in horses. Vet Rec (1998) 2.57
Amitriptyline and cardiac disease. Risk of sudden death identified by monitoring system. Lancet (1970) 2.31
A computer assisted follow-up register. Methods Inf Med (1969) 2.29
Growth, nutritional status, body composition, and energy expenditure in prepubertal children with Alagille syndrome. J Pediatr (1999) 1.95
Interpretation of dope test results in racehorses. Vet Rec (1990) 1.94
Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma. J Urol (2001) 1.92
The prevalence of enteric pathogens in diarrhoeic thoroughbred foals in Britain and Ireland. Equine Vet J (1991) 1.76
Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody. J Nucl Med (2001) 1.70
Detection of myosin heavy chain mRNA during myogenesis in tissue culture by in vitro and in situ hybridization. Cell (1977) 1.66
A method for the simultaneous measurement of insulin release and B cell membrane potential in single mouse islets of Langerhans. Diabetologia (1981) 1.63
Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma. Mol Immunol (1998) 1.56
An assessment of wastage in thoroughbred racing from conception to 4 years of age. Equine Vet J (1982) 1.49
Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. Cancer Res (2001) 1.47
Prognostic value of 18F-FDG PET/CT in patients with malignant pleural mesothelioma. Mol Imaging Biol (2009) 1.42
Positron emission tomography scanning in the assessment of patients with lymphoma. Intern Med J (2004) 1.41
Antibody targeting in metastatic colon cancer: a phase I study of monoclonal antibody F19 against a cell-surface protein of reactive tumor stromal fibroblasts. J Clin Oncol (1994) 1.41
Positron emission tomography in assessing response to neoadjuvant chemotherapy for non-small-cell lung cancer. Med J Aust (1998) 1.40
Identical triplets in a thoroughbred mare. Equine Vet J (1995) 1.39
Diffuse alveolar damage in the horse. Equine Vet J (1995) 1.39
Organogenesis of lung and kidney in Thoroughbreds and ponies. Equine Vet J (2001) 1.39
The human A33 antigen is a transmembrane glycoprotein and a novel member of the immunoglobulin superfamily. Proc Natl Acad Sci U S A (1997) 1.36
Phase I/II study of iodine 125-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol (1996) 1.21
Epidemiological study of wastage among racehorses 1982 and 1983. Vet Rec (1985) 1.19
Studies with inactivated equine influenza vaccine. 1. Serological responses of ponies to graded doses of vaccine. J Hyg (Lond) (1983) 1.19
A radiographic study of the fetus in late pregnancy and during foaling. J Reprod Fertil Suppl (1979) 1.13
The technique and clinical appication of endometrial biopsy in the mare. Equine Vet J (1975) 1.09
Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3. Eur J Biochem (2000) 1.08
The fibrous architecture of the integumentary coverings of the bovine penis. J Anat (1968) 1.08
Modulation of 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) activity in the equine placenta by pregnenolone and progesterone metabolites. Equine Vet J (1995) 1.08
Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. Clin Cancer Res (1998) 1.07
Localisation of 15-hydroxy prostaglandin dehydrogenase (PGDH) and steroidogenic enzymes in the equine placenta. Equine Vet J (1995) 1.07
Preclinical analysis of the analinoquinazoline AG1478, a specific small molecule inhibitor of EGF receptor tyrosine kinase. Biochem Pharmacol (2006) 1.07
Overexpression of insulin-like growth factor binding protein-6 inhibits rhabdomyosarcoma growth in vivo. Int J Cancer (2001) 1.06
Phase I/II study of iodine 131-labeled monoclonal antibody A33 in patients with advanced colon cancer. J Clin Oncol (1994) 1.06
Paracentesis as an aid to the diagnosis of abdominal disease in the horse. Equine Vet J (1974) 1.06
Studies with inactivated equine influenza vaccine. 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8). J Hyg (Lond) (1983) 1.05
Antisperm antibodies in the semen of a stallion following testicular trauma. Equine Vet J (1990) 1.05
Positron emission tomography changes management and prognostic stratification in patients with oesophageal cancer: results of a multicentre prospective study. Eur J Nucl Med Mol Imaging (2008) 1.04
The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer (1998) 1.04
A phase 1B trial of humanized monoclonal antibody M195 (anti-CD33) in myeloid leukemia: specific targeting without immunogenicity. Blood (1994) 1.03
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide. Br J Cancer (2006) 1.01
Genital infection in mares. Vet Rec (1977) 1.01
Serum amyloid A protein (SAA) in horses: objective measurement of the acute phase response. Equine Vet J (1989) 1.01
Gene-modified T cells as immunotherapy for multiple myeloma and acute myeloid leukemia expressing the Lewis Y antigen. Gene Ther (2010) 1.00
Chromosome abnormalities as a cause of infertility in mares. J Reprod Fertil Suppl (1975) 1.00
Influence of maternal size on placental, fetal and postnatal growth in the horse. I. Development in utero. Reproduction (2002) 1.00
Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts. Cancer Res (2001) 0.98
Established, emerging and future roles of PET/CT in the management of colorectal cancer. Clin Radiol (2008) 0.98
Pulsatile insulin release and electrical activity from single ob/ob mouse islets of Langerhans. Adv Exp Med Biol (1986) 0.98
Kinetic analysis of the interaction between the monoclonal antibody A33 and its colonic epithelial antigen by the use of an optical biosensor. A comparison of immobilisation strategies. J Chromatogr A (1997) 0.97
Virus infections of horses at Newmarket, 1972 and 1973. Vet Rec (1974) 0.95
Implementation and evaluation of patient-specific three-dimensional internal dosimetry. J Nucl Med (1997) 0.95
Some reflections on clinical research. Equine Vet J (1975) 0.95
Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy. Clin Cancer Res (2000) 0.95
Identifying hypoxic tissue after acute ischemic stroke using PET and 18F-fluoromisonidazole. Neurology (1998) 0.94
Endometrial biopsy studies of mares with contagious equine metritis 1977. Equine Vet J (1978) 0.93
Effects of anabolic-androgenic steroids on the pilosebaceous unit. Cutis (1992) 0.93
Biochemical constituents of cerebrospinal fluid in premature and full term foals. Equine Vet J (1982) 0.93
In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice. Cancer Res (2000) 0.93
The development of the lung and its surfactant in the foal and in other species. J Reprod Fertil Suppl (1975) 0.93
Relative therapeutic efficacy of (125)I- and (131)I-labeled monoclonal antibody A33 in a human colon cancer xenograft. J Nucl Med (2001) 0.93
Purification and characterization of a novel restricted antigen expressed by normal and transformed human colonic epithelium. J Biol Chem (1996) 0.93
Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR. Br J Cancer (2005) 0.93
Sympathoadrenal and other responses to hypoglycaemia in the young foal. J Reprod Fertil Suppl (1987) 0.92
Role of different sponge cell types in species specific cell aggregation. Nat New Biol (1971) 0.91
The fate of hypoxic tissue on 18F-fluoromisonidazole positron emission tomography after ischemic stroke. Ann Neurol (2000) 0.91
The myosin of developing and dystrophic skeletal muscle. FEBS Lett (1974) 0.91
Endometrial biopsy as a guide to diagnosis of endometrial pathology in the mare. J Reprod Fertil Suppl (1975) 0.91
Psychological and sex features of delayed gut transit in functional gastrointestinal disorders. Gut (2000) 0.90
Thirteen cases of botulism in horses fed big bale silage. Equine Vet J (1984) 0.90
Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer. J Nucl Med (1994) 0.90
Abnormal colonic accumulation of fluorine-18-FDG in pseudomembranous colitis. J Nucl Med (1996) 0.90
A comparison of congenital heart disease in horses and man. Equine Vet J (1992) 0.90
Potassium and rubidium permeability and potassium conductance of the beta-cell membrane in mouse islets of Langerhans. Q J Exp Physiol (1986) 0.90
Construction, expression and characterisation of a single-chain diabody derived from a humanised anti-Lewis Y cancer targeting antibody using a heat-inducible bacterial secretion vector. Cancer Immunol Immunother (2001) 0.89
The identification of polymorphic microsatellite loci in the horse and their use in thoroughbred parentage testing. Br Vet J (1995) 0.89
Breast screening and surgical problems. Br J Surg (1977) 0.89
Population pharmacokinetics of sibrotuzumab, a novel therapeutic monoclonal antibody, in cancer patients. Invest New Drugs (2004) 0.88
Rapid and specific targeting of monoclonal antibody A33 to a colon cancer xenograft in nude mice. Int J Oncol (1998) 0.88
Studies on fetal, neonatal and maternal cortisol metabolism in the mare. J Reprod Fertil Suppl (1975) 0.88
Anterior cingulate activation in antipsychotic-naïve first-episode schizophrenia. Acta Psychiatr Scand (2007) 0.88
Metabolic profiles of newborn foals. J Reprod Fertil Suppl (1975) 0.88
Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-D-glucose-avid colon lesions. Mol Imaging Biol (2007) 0.87
Preliminary studies on the use of an oral progestogen to induce oestrus and ovulation in seasonally anoestrous Thoroughbred mares. Equine Vet J (1980) 0.86
Epilation. Cutis (1990) 0.86
Further studies on the use of synthetic prostaglandin analogues for inducing luteolysis in mares. Equine Vet J (1974) 0.86
Caveat vendor: technology and prepurchase examinations of horses. Equine Vet J (1998) 0.85
Respiratory distress in a newborn foal with failure to form lung lining film. Nature (1967) 0.85
Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients. Br J Clin Pharmacol (2001) 0.85
Serum cardiac troponin I concentrations in cattle with pericarditis. Vet Rec (2007) 0.84
The expanding role of PET technology in the management of patients with colorectal cancer. Ann Oncol (2007) 0.84
Imaging of brain tumor proliferative activity with iodine-131-iododeoxyuridine. J Nucl Med (1994) 0.84